IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis

BACKGROUND: Targeting the HGF/MET signaling pathway has been a viable therapeutic strategy for various cancer types due to hyperactivation of HGF/MET axis occurs frequently that leads to detrimental cancer progression and recurrence. Deciphering novel molecule mechanisms underlying complex HGF/MET s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Pei-Yi, Huang, Wei-Chieh, Tung, Shiao-Lin, Tsai, Chung-Ying, Chen, Chih Jung, Liu, Yu-Chin, Lee, Chia-Wen, Lin, Yang-Hsiang, Lin, Hung-Yu, Chen, Cheng-Yi, Yeh, Chau-Ting, Lin, Kwang-Huei, Chi, Hsiang-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361616/
https://www.ncbi.nlm.nih.gov/pubmed/35941699
http://dx.doi.org/10.1186/s13578-022-00858-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361616/
https://www.ncbi.nlm.nih.gov/pubmed/35941699
http://dx.doi.org/10.1186/s13578-022-00858-8

Ejemplares similares